Research of the EML4-ALK Gene Expression in the Pleural Effusion or Tumor Tissue From Lung Cancer Patients

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01257308

Enrollment

100

Registered

2010-12-09

Start date

2010-08-31

Completion date

2013-08-31

Last updated

2010-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer Patients

Keywords

lung cancer

Brief summary

We wants to analyse the EML4-ALK mutation rate in the patients who have non-small cell lung cancer.

Interventions

None listed

Study design

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

20 Years to No maximum

Healthy volunteers

Inclusion criteria

* 20 or more than 20 years of age * The pathological diagnosis confirmed lung cancer * Patients have achieved pleural effusion, or surgical biopsy to obtain tumor tissue specimens * The patient had signed inform consent

Exclusion criteria

* pleural effusion or tumor tissue can not be obtained * the patient is not suitable to join the research according to the judgement by the investigator

Countries

Taiwan

Outcome results